Please use this identifier to cite or link to this item:
Title: The burden of latent multidrug-resistant tuberculosis
Author: García-Basteiro, Alberto L.
Jenkins, Helen E.
Rangaka, Moleboleng
Keywords: Tuberculosi
Resistència als medicaments
Drug resistance
Issue Date: 4-Jul-2019
Publisher: Elsevier Inc.
Abstract: In the past 10 years, there has been renewed interest in the early phases of the natural history of tuberculosis.1 Estimates suggest that around 25% of the world's population could have latent tuberculosis infection,2 5–10% of whom will develop active disease during their lifetime3 (10% annually among people with HIV).4 Failure to implement effective tuberculosis control measures to manage latent infection threatens elimination goals.
Note: Reproducció del document publicat a:
It is part of: Lancet Infectious Diseases , 2019 , vol. , num. , p. 0
Related resource: 10.1016/S1473-3099(19)30271-3
ISSN: 1473-3099
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
Garcia-BasteiroAL_Lancet_Infect_Dis_2019.pdf210.16 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons